Shimin Hu

10.7k citations
160 papers · 4.1k indexed · h-index 32
Topics
Lymphoma Diagnosis and Treatment (55 papers)Acute Myeloid Leukemia Research (51 papers)Chronic Lymphocytic Leukemia Research (49 papers)
Partner nations
United StatesChinaSpain

In The Last Decade

Shimin Hu

148 papers receiving 4.0k citations

Peers

Shimin Hu
Comparison fields: 5 of 110
  • Molecular Biology 1.7k
  • Oncology 1.3k
  • Immunology 909
  • Pathology and Forensic Medicine 865
  • Genetics 857
Replace Prasad Koduru with:
Prasad Koduru United States
Sandeep S. Davé United States
Mathijs Baens Belgium
Wayne Tam United States
Massimo Geuna Italy
Roderick A.F. MacLeod Germany
Elizabeth Hyjek United States
Pulivarthi H. Rao United States
Fabrizio Vinante Italy
Jane Houldsworth United States
Shimin Hu relative to Prasad Koduru United States Prasad Koduru's profile →
Citations per field
00.5×4.3×
Prasad Koduru · 1×
Citations per year

Countries citing papers authored by Shimin Hu

Since Specialization
Citations

This map shows the geographic impact of Shimin Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shimin Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shimin Hu more than expected).

Fields of papers citing papers by Shimin Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shimin Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shimin Hu. The network helps show where Shimin Hu may publish in the future.

Co-authorship network of co-authors of Shimin Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Shimin Hu. A scholar is included among the top collaborators of Shimin Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shimin Hu. Shimin Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 6
3 0
4 2
5 0
6 1
7 17
8 8
9 10
10 0
11 3
12 29
13 13
14 53
15 0
16 111
17 6
18 8
19 18
20 86

About Shimin Hu

Shimin Hu is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 160 papers that have together received 4.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (55 papers), Acute Myeloid Leukemia Research (51 papers) and Chronic Lymphocytic Leukemia Research (49 papers). The work is most often cited by research in Genetics (857 citations), Hematology (833 citations) and Pathology and Forensic Medicine (865 citations). Shimin Hu has collaborated with scholars based in United States, China and Spain. Frequent co-authors include Xiaolu Yang, Claudius Vincenz, L. Jeffrey Medeiros, Vishva M. Dixit, Guilin Tang, Jian Ni, Mark Buller, Reiner Gentz, William F. Benedict and Wei Wang. Their work appears in journals such as Cell, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026